• home
  • ABOUT
    • company profile
    • Strategy
    • Management Team & Board Of Directors
  • Products
    • PRF-110
    • Product Pipeline
    • Clinical Trials
  • Market
  • Investors
    • press releases
      • sec filling
    • presentations
    • events
    • governance
    • stock chart
  • Contact
Menu
  • home
  • ABOUT
    • company profile
    • Strategy
    • Management Team & Board Of Directors
  • Products
    • PRF-110
    • Product Pipeline
    • Clinical Trials
  • Market
  • Investors
    • press releases
      • sec filling
    • presentations
    • events
    • governance
    • stock chart
  • Contact

Investor relations

  • Investors lobby
  • company profile
  • press releases
  • presentations
  • events
  • governance
  • stock chart
  • Sec Filings
  • Contact
Menu
  • Investors lobby
  • company profile
  • press releases
  • presentations
  • events
  • governance
  • stock chart
  • Sec Filings
  • Contact

press releases

11/15/2023

PainReform Provides Business Update for the Third Quarter of 2023

read more
09/11/2023

PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trialto Evaluate PRF-110 in Patients Undergoing Bunionectomy SurgeryFollowing Positive FDA Review of Drug Master File

read more
09/07/2023

PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary

read more
09/05/2023

PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City

read more
08/10/2023

PainReform Provides Business Update for the Second Quarter of 2023

read more
07/12/2023

PainReformAnnounces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement

read more

© 2021 PainReform

Privacy Policy

Terms of Use

this site made by